Unknown

Dataset Information

Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols.


ABSTRACT:

Background

Notwithstanding the efforts of direct-acting antivirals (DAAs) for the treatment of chronically infected hepatitis C virus (HCV) patients, concerns exist regarding the emergence of resistance-associated substitutions (RAS) related to therapy failure. Sanger sequencing is still the reference technique used for the detection of RAS and it detects viral variants present up to 15%, meaning that minority variants are undetectable, using this technique. To date, many studies are focused on the analysis of the impact of HCV low variants using next-generation sequencing (NGS) techniques, but the importance of these minority variants is still debated, and importantly, a common data analysis method is still not defined.

Methods

Serum samples from four patients failing DAAs

SUBMITTER: Caputo V 

PROVIDER: S-EPMC7359454 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature